NUDT1 and neoplasm: All three osteosarcoma tumours—zccs225, zccs43, and zccs265—harboured structural variations in TP53. Targeted sequencing confirmed the preservation of the TP53-NUDT1 fusion in the matching bioprinted tumouroid for zccs225 (Fig. 3B).